Table of Contents 1 Market Overview 1.1 IDO Inhibitors Introduction 1.2 Market Analysis by Type 1.2.1 Dual IDO1/TDO inhibitors 1.2.2 Covalent IDO inhibitors 1.3 Market Analysis by Applications 1.3.1 Metastatic Melanoma 1.3.2 Metastatic Pancreatic Cancer 1.3.3 mCRPC 1.3.4 Malignant Glioma 1.3.5 Astrocytoma 1.3.6 Breast Cancer 1.4 Market Analysis by Regions 1.4.1 North America (United States, Canada and Mexico) 1.4.1.1 United States Market States and Outlook (2013-2023) 1.4.1.2 Canada Market States and Outlook (2013-2023) 1.4.1.3 Mexico Market States and Outlook (2013-2023) 1.4.2 Europe (Germany, France, UK, Russia and Italy) 1.4.2.1 Germany Market States and Outlook (2013-2023) 1.4.2.2 France Market States and Outlook (2013-2023) 1.4.2.3 UK Market States and Outlook (2013-2023) 1.4.2.4 Russia Market States and Outlook (2013-2023) 1.4.2.5 Italy Market States and Outlook (2013-2023) 1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) 1.4.3.1 China Market States and Outlook (2013-2023) 1.4.3.2 Japan Market States and Outlook (2013-2023) 1.4.3.3 Korea Market States and Outlook (2013-2023) 1.4.3.4 India Market States and Outlook (2013-2023) 1.4.3.5 Southeast Asia Market States and Outlook (2013-2023) 1.4.4 South America, Middle East and Africa 1.4.4.1 Brazil Market States and Outlook (2013-2023) 1.4.4.2 Egypt Market States and Outlook (2013-2023) 1.4.4.3 Saudi Arabia Market States and Outlook (2013-2023) 1.4.4.4 South Africa Market States and Outlook (2013-2023) 1.4.4.5 Nigeria Market States and Outlook (2013-2023) 1.5 Market Dynamics 1.5.1 Market Opportunities 1.5.2 Market Risk 1.5.3 Market Driving Force 2 Manufacturers Profiles 2.1 Pfizer 2.1.1 Business Overview 2.1.2 IDO Inhibitors Type and Applications 2.1.2.1 Product A 2.1.2.2 Product B 2.1.3 Pfizer IDO Inhibitors Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) 2.2 Bristol-Myers Squibb 2.2.1 Business Overview 2.2.2 IDO Inhibitors Type and Applications 2.2.2.1 Product A 2.2.2.2 Product B 2.2.3 Bristol-Myers Squibb IDO Inhibitors Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) 2.3 Kyowa Hakko Kirin 2.3.1 Business Overview 2.3.2 IDO Inhibitors Type and Applications 2.3.2.1 Product A 2.3.2.2 Product B 2.3.3 Kyowa Hakko Kirin IDO Inhibitors Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) 3 Global IDO Inhibitors Sales, Revenue, Market Share and Competition by Manufacturer (2016-2017) 3.1 Global IDO Inhibitors Sales and Market Share by Manufacturer (2016-2017) 3.2 Global IDO Inhibitors Revenue and Market Share by Manufacturer (2016-2017) 3.3 Market Concentration Rate 3.3.1 Top 3 IDO Inhibitors Manufacturer Market Share in 2017 3.3.2 Top 6 IDO Inhibitors Manufacturer Market Share in 2017 3.4 Market Competition Trend 4 Global IDO Inhibitors Market Analysis by Regions 4.1 Global IDO Inhibitors Sales, Revenue and Market Share by Regions 4.1.1 Global IDO Inhibitors Sales and Market Share by Regions (2013-2018) 4.1.2 Global IDO Inhibitors Revenue and Market Share by Regions (2013-2018) 4.2 North America IDO Inhibitors Sales and Growth Rate (2013-2018) 4.3 Europe IDO Inhibitors Sales and Growth Rate (2013-2018) 4.4 Asia-Pacific IDO Inhibitors Sales and Growth Rate (2013-2018) 4.5 South America IDO Inhibitors Sales and Growth Rate (2013-2018) 4.6 Middle East and Africa IDO Inhibitors Sales and Growth Rate (2013-2018) 5 North America IDO Inhibitors by Countries 5.1 North America IDO Inhibitors Sales, Revenue and Market Share by Countries 5.1.1 North America IDO Inhibitors Sales and Market Share by Countries (2013-2018) 5.1.2 North America IDO Inhibitors Revenue and Market Share by Countries (2013-2018) 5.2 United States IDO Inhibitors Sales and Growth Rate (2013-2018) 5.3 Canada IDO Inhibitors Sales and Growth Rate (2013-2018) 5.4 Mexico IDO Inhibitors Sales and Growth Rate (2013-2018) 6 Europe IDO Inhibitors by Countries 6.1 Europe IDO Inhibitors Sales, Revenue and Market Share by Countries 6.1.1 Europe IDO Inhibitors Sales and Market Share by Countries (2013-2018) 6.1.2 Europe IDO Inhibitors Revenue and Market Share by Countries (2013-2018) 6.2 Germany IDO Inhibitors Sales and Growth Rate (2013-2018) 6.3 UK IDO Inhibitors Sales and Growth Rate (2013-2018) 6.4 France IDO Inhibitors Sales and Growth Rate (2013-2018) 6.5 Russia IDO Inhibitors Sales and Growth Rate (2013-2018) 6.6 Italy IDO Inhibitors Sales and Growth Rate (2013-2018) 7 Asia-Pacific IDO Inhibitors by Countries 7.1 Asia-Pacific IDO Inhibitors Sales, Revenue and Market Share by Countries 7.1.1 Asia-Pacific IDO Inhibitors Sales and Market Share by Countries (2013-2018) 7.1.2 Asia-Pacific IDO Inhibitors Revenue and Market Share by Countries (2013-2018) 7.2 China IDO Inhibitors Sales and Growth Rate (2013-2018) 7.3 Japan IDO Inhibitors Sales and Growth Rate (2013-2018) 7.4 Korea IDO Inhibitors Sales and Growth Rate (2013-2018) 7.5 India IDO Inhibitors Sales and Growth Rate (2013-2018) 7.6 Southeast Asia IDO Inhibitors Sales and Growth Rate (2013-2018) 8 South America IDO Inhibitors by Countries 8.1 South America IDO Inhibitors Sales, Revenue and Market Share by Countries 8.1.1 South America IDO Inhibitors Sales and Market Share by Countries (2013-2018) 8.1.2 South America IDO Inhibitors Revenue and Market Share by Countries (2013-2018) 8.2 Brazil IDO Inhibitors Sales and Growth Rate (2013-2018) 8.3 Argentina IDO Inhibitors Sales and Growth Rate (2013-2018) 8.4 Colombia IDO Inhibitors Sales and Growth Rate (2013-2018) 9 Middle East and Africa IDO Inhibitors by Countries 9.1 Middle East and Africa IDO Inhibitors Sales, Revenue and Market Share by Countries 9.1.1 Middle East and Africa IDO Inhibitors Sales and Market Share by Countries (2013-2018) 9.1.2 Middle East and Africa IDO Inhibitors Revenue and Market Share by Countries (2013-2018) 9.2 Saudi Arabia IDO Inhibitors Sales and Growth Rate (2013-2018) 9.3 UAE IDO Inhibitors Sales and Growth Rate (2013-2018) 9.4 Egypt IDO Inhibitors Sales and Growth Rate (2013-2018) 9.5 Nigeria IDO Inhibitors Sales and Growth Rate (2013-2018) 9.6 South Africa IDO Inhibitors Sales and Growth Rate (2013-2018) 10 Global IDO Inhibitors Market Segment by Type 10.1 Global IDO Inhibitors Sales, Revenue and Market Share by Type (2013-2018) 10.1.1 Global IDO Inhibitors Sales and Market Share by Type (2013-2018) 10.1.2 Global IDO Inhibitors Revenue and Market Share by Type (2013-2018) 10.2 Dual IDO1/TDO inhibitors Sales Growth and Price 10.2.1 Global Dual IDO1/TDO inhibitors Sales Growth (2013-2018) 10.2.2 Global Dual IDO1/TDO inhibitors Price (2013-2018) 10.3 Covalent IDO inhibitors Sales Growth and Price 10.3.1 Global Covalent IDO inhibitors Sales Growth (2013-2018) 10.3.2 Global Covalent IDO inhibitors Price (2013-2018) 11 Global IDO Inhibitors Market Segment by Application 11.1 Global IDO Inhibitors Sales Market Share by Application (2013-2018) 11.2 Metastatic Melanoma Sales Growth (2013-2018) 11.3 Metastatic Pancreatic Cancer Sales Growth (2013-2018) 11.4 mCRPC Sales Growth (2013-2018) 11.5 Malignant Glioma Sales Growth (2013-2018) 11.6 Astrocytoma Sales Growth (2013-2018) 11.7 Breast Cancer Sales Growth (2013-2018) 12 IDO Inhibitors Market Forecast (2018-2023) 12.1 Global IDO Inhibitors Sales, Revenue and Growth Rate (2018-2023) 12.2 IDO Inhibitors Market Forecast by Regions (2018-2023) 12.2.1 North America IDO Inhibitors Market Forecast (2018-2023) 12.2.2 Europe IDO Inhibitors Market Forecast (2018-2023) 12.2.3 Asia-Pacific IDO Inhibitors Market Forecast (2018-2023) 12.2.4 South America IDO Inhibitors Market Forecast (2018-2023) 12.2.5 Middle East and Africa IDO Inhibitors Market Forecast (2018-2023) 12.3 IDO Inhibitors Market Forecast by Type (2018-2023) 12.3.1 Global IDO Inhibitors Sales Forecast by Type (2018-2023) 12.3.2 Global IDO Inhibitors Market Share Forecast by Type (2018-2023) 12.4 IDO Inhibitors Market Forecast by Application (2018-2023) 12.4.1 Global IDO Inhibitors Sales Forecast by Application (2018-2023) 12.4.2 Global IDO Inhibitors Market Share Forecast by Application (2018-2023) 13 Sales Channel, Distributors, Traders and Dealers 13.1 Sales Channel 13.1.1 Direct Marketing 13.1.2 Indirect Marketing 13.1.3 Marketing Channel Future Trend 13.2 Distributors, Traders and Dealers 14 Research Findings and Conclusion 15 Appendix 15.1 Methodology 15.2 Data Source

List of Tables and Figures Figure IDO Inhibitors Picture Table Product Specifications of IDO Inhibitors Figure Global Sales Market Share of IDO Inhibitors by Types in 2017 Table IDO Inhibitors Types for Major Manufacturers Figure Dual IDO1/TDO inhibitors Picture Figure Covalent IDO inhibitors Picture Figure IDO Inhibitors Sales Market Share by Applications in 2017 Figure Metastatic Melanoma Picture Figure Metastatic Pancreatic Cancer Picture Figure mCRPC Picture Figure Malignant Glioma Picture Figure Astrocytoma Picture Figure Breast Cancer Picture Figure United States IDO Inhibitors Revenue (Value) and Growth Rate (2013-2023) Figure Canada IDO Inhibitors Revenue (Value) and Growth Rate (2013-2023) Figure Mexico IDO Inhibitors Revenue (Value) and Growth Rate (2013-2023) Figure Germany IDO Inhibitors Revenue (Value) and Growth Rate (2013-2023) Figure France IDO Inhibitors Revenue (Value) and Growth Rate (2013-2023) Figure UK IDO Inhibitors Revenue (Value) and Growth Rate (2013-2023) Figure Russia IDO Inhibitors Revenue (Value) and Growth Rate (2013-2023) Figure Italy IDO Inhibitors Revenue (Value) and Growth Rate (2013-2023) Figure China IDO Inhibitors Revenue (Value) and Growth Rate (2013-2023) Figure Japan IDO Inhibitors Revenue (Value) and Growth Rate (2013-2023) Figure Korea IDO Inhibitors Revenue (Value) and Growth Rate (2013-2023) Figure India IDO Inhibitors Revenue (Value) and Growth Rate (2013-2023) Figure Southeast Asia IDO Inhibitors Revenue (Value) and Growth Rate (2013-2023) Figure Brazil IDO Inhibitors Revenue (Value) and Growth Rate (2013-2023) Figure Egypt IDO Inhibitors Revenue (Value) and Growth Rate (2013-2023) Figure Saudi Arabia IDO Inhibitors Revenue (Value) and Growth Rate (2013-2023) Figure South Africa IDO Inhibitors Revenue (Value) and Growth Rate (2013-2023) Figure Nigeria IDO Inhibitors Revenue (Value) and Growth Rate (2013-2023) Table Pfizer Basic Information, Manufacturing Base and Competitors Table Pfizer IDO Inhibitors Type and Applications Table Pfizer IDO Inhibitors Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) Table Bristol-Myers Squibb Basic Information, Manufacturing Base and Competitors Table Bristol-Myers Squibb IDO Inhibitors Type and Applications Table Bristol-Myers Squibb IDO Inhibitors Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) Table Kyowa Hakko Kirin Basic Information, Manufacturing Base and Competitors Table Kyowa Hakko Kirin IDO Inhibitors Type and Applications Table Kyowa Hakko Kirin IDO Inhibitors Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) Table Global IDO Inhibitors Sales by Manufacturer (2016-2017) Figure Global IDO Inhibitors Sales Market Share by Manufacturer in 2016 Figure Global IDO Inhibitors Sales Market Share by Manufacturer in 2017 Table Global IDO Inhibitors Revenue by Manufacturer (2016-2017) Figure Global IDO Inhibitors Revenue Market Share by Manufacturer in 2016 Figure Global IDO Inhibitors Revenue Market Share by Manufacturer in 2017 Figure Top 3 IDO Inhibitors Manufacturer (Revenue) Market Share in 2017 Figure Top 6 IDO Inhibitors Manufacturer (Revenue) Market Share in 2017 Figure Global IDO Inhibitors Sales and Growth Rate (2013-2018) Figure Global IDO Inhibitors Revenue and Growth Rate (2013-2018) Table Global IDO Inhibitors Sales by Regions (2013-2018) Table Global IDO Inhibitors Sales Market Share by Regions (2013-2018) Table Global IDO Inhibitors Revenue by Regions (2013-2018) Figure Global IDO Inhibitors Revenue Market Share by Regions in 2013 Figure Global IDO Inhibitors Revenue Market Share by Regions in 2017 Figure North America IDO Inhibitors Sales and Growth Rate (2013-2018) Figure Europe IDO Inhibitors Sales and Growth Rate (2013-2018) Figure Asia-Pacific IDO Inhibitors Sales and Growth Rate (2013-2018) Figure South America IDO Inhibitors Sales and Growth Rate (2013-2018) Figure Middle East and Africa IDO Inhibitors Sales and Growth Rate (2013-2018) Figure North America IDO Inhibitors Revenue and Growth Rate (2013-2018) Table North America IDO Inhibitors Sales by Countries (2013-2018) Table North America IDO Inhibitors Sales Market Share by Countries (2013-2018) Figure North America IDO Inhibitors Sales Market Share by Countries in 2013 Figure North America IDO Inhibitors Sales Market Share by Countries in 2017 Table North America IDO Inhibitors Revenue by Countries (2013-2018) Table North America IDO Inhibitors Revenue Market Share by Countries (2013-2018) Figure North America IDO Inhibitors Revenue Market Share by Countries in 2013 Figure North America IDO Inhibitors Revenue Market Share by Countries in 2017 Figure United States IDO Inhibitors Sales and Growth Rate (2013-2018) Figure Canada IDO Inhibitors Sales and Growth Rate (2013-2018) Figure Mexico IDO Inhibitors Sales and Growth Rate (2013-2018) Figure Europe IDO Inhibitors Revenue and Growth Rate (2013-2018) Table Europe IDO Inhibitors Sales by Countries (2013-2018) Table Europe IDO Inhibitors Sales Market Share by Countries (2013-2018) Table Europe IDO Inhibitors Revenue by Countries (2013-2018) Figure Europe IDO Inhibitors Revenue Market Share by Countries in 2016 Figure Europe IDO Inhibitors Revenue Market Share by Countries in 2017 Figure Germany IDO Inhibitors Sales and Growth Rate (2013-2018) Figure UK IDO Inhibitors Sales and Growth Rate (2013-2018) Figure France IDO Inhibitors Sales and Growth Rate (2013-2018) Figure Russia IDO Inhibitors Sales and Growth Rate (2013-2018) Figure Italy IDO Inhibitors Sales and Growth Rate (2013-2018) Figure Asia-Pacific IDO Inhibitors Revenue and Growth Rate (2013-2018) Table Asia-Pacific IDO Inhibitors Sales by Countries (2013-2018) Table Asia-Pacific IDO Inhibitors Sales Market Share by Countries (2013-2018) Figure Asia-Pacific IDO Inhibitors Sales Market Share by Countries 2017 Table Asia-Pacific IDO Inhibitors Revenue by Countries (2013-2018) Figure Asia-Pacific IDO Inhibitors Revenue Market Share by Countries 2017 Figure China IDO Inhibitors Sales and Growth Rate (2013-2018) Figure Japan IDO Inhibitors Sales and Growth Rate (2013-2018) Figure Korea IDO Inhibitors Sales and Growth Rate (2013-2018) Figure India IDO Inhibitors Sales and Growth Rate (2013-2018) Figure Southeast Asia IDO Inhibitors Sales and Growth Rate (2013-2018) Figure South America IDO Inhibitors Revenue and Growth Rate (2013-2018) Table South America IDO Inhibitors Sales by Countries (2013-2018) Table South America IDO Inhibitors Sales Market Share by Countries (2013-2018) Figure South America IDO Inhibitors Sales Market Share by Countries in 2017 Table South America IDO Inhibitors Revenue by Countries (2013-2018) Table South America IDO Inhibitors Revenue Market Share by Countries (2013-2018) Figure South America IDO Inhibitors Revenue Market Share by Countries in 2017 Figure Brazil IDO Inhibitors Sales and Growth Rate (2013-2018) Figure Argentina IDO Inhibitors Sales and Growth Rate (2013-2018) Figure Colombia IDO Inhibitors Sales and Growth Rate (2013-2018) Figure Middle East and Africa IDO Inhibitors Revenue and Growth Rate (2013-2018) Table Middle East and Africa IDO Inhibitors Sales by Countries (2013-2018) Table Middle East and Africa IDO Inhibitors Sales Market Share by Countries (2013-2018) Figure Middle East and Africa IDO Inhibitors Sales Market Share by Countries in 2017 Table Middle East and Africa IDO Inhibitors Revenue by Countries (2013-2018) Table Middle East and Africa IDO Inhibitors Revenue Market Share by Countries (2013-2018) Figure Middle East and Africa IDO Inhibitors Revenue Market Share by Countries in 2013 Figure Middle East and Africa IDO Inhibitors Revenue Market Share by Countries in 2017 Figure Saudi Arabia IDO Inhibitors Sales and Growth Rate (2013-2018) Figure UAE IDO Inhibitors Sales and Growth Rate (2013-2018) Figure Egypt IDO Inhibitors Sales and Growth Rate (2013-2018) Figure Nigeria IDO Inhibitors Sales and Growth Rate (2013-2018) Figure South Africa IDO Inhibitors Sales and Growth Rate (2013-2018) Table Global IDO Inhibitors Sales by Type (2013-2018) Table Global IDO Inhibitors Sales Share by Type (2013-2018) Table Global IDO Inhibitors Revenue by Type (2013-2018) Table Global IDO Inhibitors Revenue Share by Type (2013-2018) Figure Global Dual IDO1/TDO inhibitors Sales Growth (2013-2018) Figure Global Dual IDO1/TDO inhibitors Price (2013-2018) Figure Global Covalent IDO inhibitors Sales Growth (2013-2018) Figure Global Covalent IDO inhibitors Price (2013-2018) Table Global IDO Inhibitors Sales by Application (2013-2018) Table Global IDO Inhibitors Sales Share by Application (2013-2018) Figure Global Metastatic Pancreatic Cancer Sales Growth (2013-2018) Figure Global mCRPC Sales Growth (2013-2018) Figure Global Malignant Glioma Sales Growth (2013-2018) Figure Global Astrocytoma Sales Growth (2013-2018) Figure Global Breast Cancer Sales Growth (2013-2018) Figure Global IDO Inhibitors Sales, Revenue and Growth Rate (2018-2023) Table Global IDO Inhibitors Sales Forecast by Regions (2018-2023) Table Global IDO Inhibitors Market Share Forecast by Regions (2018-2023) Figure North America Sales IDO Inhibitors Market Forecast (2018-2023) Figure Europe Sales IDO Inhibitors Market Forecast (2018-2023) Figure Asia-Pacific Sales IDO Inhibitors Market Forecast (2018-2023) Figure South America Sales IDO Inhibitors Market Forecast (2018-2023) Figure Middle East and Africa Sales IDO Inhibitors Market Forecast (2018-2023) Table Global IDO Inhibitors Sales Forecast by Type (2018-2023) Table Global IDO Inhibitors Market Share Forecast by Type (2018-2023) Table Global IDO Inhibitors Sales Forecast by Application (2018-2023) Table Global IDO Inhibitors Market Share Forecast by Application (2018-2023) Table Distributors/Traders/ Dealers List

Pfizer Bristol-Myers Squibb Kyowa Hakko Kirin